Your search returned 277 results.

Results
	101.	Quantitative determination of the antidepressant vortioxetine and its major human metabolite in plasma. [electronic resource] by Kall, Morten A Rohde, Morten Jørgensen, Martin Producer: 20160913 In: Bioanalysis vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	102.	A randomized trial on the acute and steady-state effects of a new antidepressant, vortioxetine (Lu AA21004), on actual driving and cognition. [electronic resource] by Theunissen, E L Street, D Højer, A-M Vermeeren, A van Oers, A Ramaekers, J G Producer: 20130723 In: Clinical pharmacology and therapeutics vol. 93 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	103.	Efficacy and tolerability of different doses of three new antidepressants for treating major depressive disorder: A PRISMA-compliant meta-analysis. [electronic resource] by He, Hairong Wang, Wei Lyu, Jun Zheng, Jie Guo, Liyang An, Xiaofang Fan, Yajuan Ma, Xiancang Producer: 20180706 In: Journal of psychiatric research vol. 96 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	104.	Effects of vortioxetine on biomarkers associated with glutamatergic activity in an SSRI insensitive model of depression in female rats. [electronic resource] by Hlavacova, N Li, Y Pehrson, A Sanchez, C Bermudez, I Csanova, A Jezova, D Franklin, M Producer: 20190122 In: Progress in neuro-psychopharmacology & biological psychiatry vol. 82 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	105.	Modeling and Mutational Analysis of the Binding Mode for the Multimodal Antidepressant Drug Vortioxetine to the Human 5-HT [electronic resource] by Ladefoged, Lucy Kate Munro, Lachlan Pedersen, Anders J Lummis, Sarah C R Bang-Andersen, Benny Balle, Thomas Schiøtt, Birgit Kristensen, Anders S Producer: 20190503 In: Molecular pharmacology vol. 94 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	106.	Multimodal antidepressant vortioxetine causes analgesia in a mouse model of chronic neuropathic pain. [electronic resource] by Zuena, Anna Rita Maftei, Daniela Alemà, Giovanni Sebastiano Dal Moro, Francesca Lattanzi, Roberta Casolini, Paola Nicoletti, Ferdinando Producer: 20190220 In: Molecular pain vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	107.	Successfully treated patients with vortioxetine versus venlafaxine: a simplified cost-effectiveness analysis based on a head-to-head study in Asian patients with major depressive disorder. [electronic resource] by Wang, Gang Zhao, Kun Reynaud-Mougin, Caroline Loft, Henrik Ren, Hongye Eriksen, Hanne-Lise F Ettrup, Anders Producer: 20210311 In: Current medical research and opinion vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	108.	The effect of vortioxetine on health-related quality of life in patients with major depressive disorder. [electronic resource] by Florea, Ioana Danchenko, Natalya Brignone, Melanie Loft, Henrik Rive, Benoit Abetz-Webb, Linda Producer: 20160517 In: Clinical therapeutics vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	109.	Cost-utility evaluation of vortioxetine in patients with Major Depressive Disorder experiencing inadequate response to alternative antidepressants in the United Kingdom. [electronic resource] by Young, A H Evitt, L Brignone, M Diamand, F Atsou, K Campbell, R Cure, S Danchenko, N Producer: 20180209 In: Journal of affective disorders vol. 218 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	110.	Vortioxetine for major depressive disorder, vasomotor, and cognitive symptoms associated with the menopausal transition. [electronic resource] by Freeman, Marlene P Cheng, Laura J Moustafa, Danna Davies, Abigail Sosinsky, Alexandra Z Wang, Betty Petrillo, Laura F Hogan, Charlotte Cohen, Lee S Producer: 20180725 In: Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists vol. 29 Availability: No items available. Save to lists Add to cart (remove)
	111.	Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): enhancing serotonin release by combining serotonin (5HT) transporter inhibition with actions at 5HT receptors (5HT1A, 5HT1B, 5HT1D, 5HT7 receptors). [electronic resource] by Stahl, Stephen M Producer: 20150915 In: CNS spectrums vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	112.	Pharmacokinetic evaluation of vortioxetine for the treatment of major depressive disorder. [electronic resource] by Dubovsky, Steven L Producer: 20141218 In: Expert opinion on drug metabolism & toxicology vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	113.	Relative short-term efficacy and acceptability of agomelatine versus vortioxetine in adult patients suffering from major depressive disorder. [electronic resource] by Kennedy, Sidney H Grouin, Jean-Marie Cadour, Stéphanie Robert, Véronique Picarel-Blanchot, Françoise Producer: 20190211 In: Human psychopharmacology vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	114.	Vortioxetine Subchronically Activates Serotonergic Transmission via Desensitization of Serotonin 5-HT [electronic resource] by Okada, Motohiro Okubo, Ruri Fukuyama, Kouji Producer: 20200427 In: International journal of molecular sciences vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	115.	Randomized, double-blind, placebo-controlled 8-week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressive disorder. [electronic resource] by Nishimura, Akira Aritomi, Yutaka Sasai, Kiyofumi Kitagawa, Tadayuki Mahableshwarkar, Atul R Producer: 20180824 In: Psychiatry and clinical neurosciences vol. 72 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	116.	Vortioxetine: a New Treatment for Major Depressive Disorder. [electronic resource] by Connolly, K Ryan Thase, Michael E Producer: 20160714 In: Expert opinion on pharmacotherapy vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	117.	Vortioxetine administration attenuates cognitive and synaptic deficits in 5×FAD mice. [electronic resource] by Jiang, Li-Xin Huang, Geng-Di Su, Feng Wang, Huali Zhang, Chen Yu, Xin Producer: 20200914 In: Psychopharmacology vol. 237 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	118.	Effects of Vortioxetine and Escitalopram on Electroencephalographic Recordings - A Randomized, Crossover Trial in Healthy Males. [electronic resource] by Nissen, Thomas Dahl Laursen, Bettina Viardot, Geoffrey l'Hostis, Philippe Danjou, Philippe Sluth, Lasse Breuning Gram, Mikkel Bastlund, Jesper Frank Christensen, Søren Rahn Drewes, Asbjørn Mohr Producer: 20201210 In: Neuroscience vol. 424 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	119.	[Pharmacological properties of vortioxetine and its pre-clinical consequences]. [electronic resource] by David, D J Tritschler, L Guilloux, J-P Gardier, A M Sanchez, C Gaillard, R Producer: 20161213 In: L'Encephale vol. 42 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	120.	Task- and Treatment Length-Dependent Effects of Vortioxetine on Scopolamine-Induced Cognitive Dysfunction and Hippocampal Extracellular Acetylcholine in Rats. [electronic resource] by Pehrson, Alan L Hillhouse, Todd M Haddjeri, Nasser Rovera, Renaud Porter, Joseph H Mørk, Arne Smagin, Gennady Song, Dekun Budac, David Cajina, Manuel Sanchez, Connie Producer: 20170526 In: The Journal of pharmacology and experimental therapeutics vol. 358 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
1
2
3
4
5
6
7
8
9
10
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 277 results.